| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Adenocarcinoma | 6468837 | CTD | |
| 2 | Bladder papilloma | Canada Vigilance: 1 | Canada Vigilance | |
| 3 | Carcinoma, Transitional Cell | 3731063 7248968 | CTD | |
| 4 | Carcinoma | 3779637 | CTD | |
| 5 | Diarrhea | 7448750 | CTD | |
| 6 | Disruptive, Impulse Control, and Conduct Disorders | 18690116 | CTD | |
| 7 | Gastritis | 3731063 | CTD | |
| 8 | Hyperplasia | CTD | ||
| 9 | Hypoglycemia | 7448750 | CTD | |
| 10 | Kidney Diseases | 3764937 7135424 | CTD | |
| 11 | Neoplasms, Experimental | CTD | ||
| 12 | Papilloma | 3731063 7248968 7429086 | CTD | |
| 13 | Precancerous Conditions | 2444767 7306987 7429086 | CTD | |
| 14 | Stomach Neoplasms | 6468837 | CTD | |
| 15 | Urinary Bladder Diseases | 25891526 | CTD | |
| 16 | Weight Gain | 7448750 | CTD |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120263
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.